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Abstract 
Objective: Selenium deficiency is a risk factor for Kashin-Beck disease (KBD), an endemic 
osteoarthropathy. Although promoter hypermethylation of glutathione peroxidase 3 (GPX3) 
(a selenoprotein) has been identified in several cancers, little is known about promoter 
methylation and expression of GPX3 and their relation to selenium in KBD. The present 
study was thus conducted to investigate this research question. 
Methods: Methylation and expressions of GPX3 in whole blood drawn from 288 KBD 
patients and 362 healthy controls and in chondrocyte cell line were evaluated using 
methylation-specific PCR and qRT-PCR, respectively. The protein levels of PI3K/Akt/c-fos 
signaling in the whole blood and chondrocyte cell line were determined with Western 
blotting. Chondrocytes apoptosis were detected by Hoechst 33342 and Annexin V-FITC/PI 
staining. 
Results: GPX3 methylation was increased, GPX3 mRNA was decreased, and protein levels 
in the PI3K/Akt/c-fos signaling pathway were up-regulated in the whole blood collected from 
KBD patients as compared with healthy controls. Similar results were obtained for 
chondrocytes injured by oxidative stress. There was a significant, decreasing trend in GPX3 
expression across groups of unmethylation, partial methylation, and complete methylation for 
GPX3, in sequence. Compared with unmethylation group, protein levels in PI3K/Akt/c-fos 
pathway were enhanced in partial and complete methylation groups. Treatment of 
chondrocytes with sodium selenite resulted in reduced methylation and increased expression 
of GPX3 as well as down-regulated level of PI3K/Akt/c-fos proteins. 
Conclusions: The methylation and expression of GPX3 and expression of PI3K/Akt/c-fos 
pathway are altered in KBD and these changes are reversible by selenium supplementation. 
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1. Introduction 
Kashin-Beck Disease (KBD) is an endemic osteoarthropathy that primarily occurs among 
children and adolescents and is manifested by joint pain, arthritis, muscle atrophy, deformed 
joints, and even dwarfism (1). The main pathological features of KBD are cartilage necrosis 
and excessive apoptosis of chondrocytes in the deep layers of epiphysis and articular cartilage 
(2, 3). KBD is prevalent in a large belt extending from Southeast Siberia, North Korea, 
Northeast China, to Southwest China (4). In China, more than 104 million people reside in 
KBD-affected areas, and 567,637 people were diagnosed with the disease, including 12,730 
patients under 13 years of age (5). The etiology and pathogenesis of KBD largely remain 
unclear. A growing body of epidemiological evidence suggests that KBD develops as a 
consequence of the interaction between genes and environmental factors (6, 7). Selenium 
deficiency was observed to be an environmental risk factor for KBD in most epidemiological 
studies (3, 8), but the biochemical mechanisms by which selenium deficiency induces 
cartilage damage and thereby leads to an elevated risk of KBD are yet to be elucidated. 
Epigenetics provides an optimal framework for investigating the mechanisms of 
environmental factors in KBD development. It is well documented that gene expression is 
regulated by epigenetic modifications, especially DNA methylation, in response to 
environmental exposures in a variety of diseases (9, 10). DNA hypermethylation is 
considered an important gene modification that prevents the recruitment of transcription 
factors and consequently suppresses the transcription of various genes (11). Several studies 
have revealed that selenium is involved in epigenetic modifications (12, 13). Selenoproteins 
are the main form of selenium that are responsible for numerous biological functions. One of 
these selenoproteins is glutathione peroxidases 3 (GPX3), a primary antioxidant enzyme in 
the human body (14). It is possible that epigenetic modifications of GPX3 induced by 
oxidative stress modulate antioxidant gene transcription and mRNA stability. GPX3 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 5 
differential methylation has been linked to cervical cancer, breast cancer, and multiple 
myeloma (15-17). Therefore, the methylation status of GPX3 may also play a role in the 
pathogenesis of KBD and other diseases related to oxidative stress. 
Some studies have demonstrated that the phosphatidylinositol 3-kinase (PI3K)/protein 
kinase B (Akt)/c-fos signaling pathway is involved in celllular oxidative damage and 
apoptosis (18, 19). In addition, the differential level of PI3K/Akt pathway were found in 
KBD patients compared with controls and related to selenoprotein S (SEPS1) -105G>A 
polymorphisms (7). However, GPX3 DNA methylation status and its potential influence on 
cartilage damage among KBD patients have not been investigated up to date. Therefore, the 
present study was conducted to evaluate the association between GPX3 DNA methylation 
and KBD risk and to elucidate the mechanisms of GPX3 DNA methylation in the 
development of cartilage damage. 
2. Materials and methods 
2.1. Study population 
KBD was diagnosed using the criteria of National Health Commission of the People’s 
Republic of China (WS/T207-2010). A total of 288 KBD cases and 362 controls were 
recruited from KBD endemic and non-endemic areas in Shaanxi province, respectively, 
which excluded osteoarthritis and other joint diseases. All subjects enrolled to the present 
study were Han Chinese. Cases and controls were comparable with regard to age and sex. 
The study protocol was approved by the Human Ethics Committee of Xi'an Jiaotong 
University, and a written informed consent was obtained from each of the study subjects prior 
to in-person interview and blood collection. 
A peripheral venous blood sample (5 ml) procured from each of study subjects were 
extracted for DNA, total mRNA, and proteins, and stored in freezers (-80℃) until analysis. 
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Independent experiments for GPX3 DNA methylation, GPX3 mRNA expression, and protein 
level described below were each repeated at least three times. 
2.2. GPX3 DNA methylation 
Genomic DNA were extracted from blood and chondrocytes using TIANamp Genomic 
DNA Kit (Tiangen Biotech, Beijing, China). Bisulfite conversion for methylation-specific 
polymerase chain reaction (MSP) was performed with EZ DNA Methylation Kit (ZYMO 
Research, Irvine, CA) according to the manufacturer’s instructions. The methylation primers 
and unmethylation primers were used to amplify the 177-bp and 186-bp products from target 
sequences, respectively (20). The primer sequences are as follows: methylated primers (F: 
5’-TATGTTATTGTCGTTTCGGGAC-3’; R: 5’-GTCCGTCTAAAATATCCGACG-3’) and 
unmethylated primers (F: 5’-TTTATGTTATTGTTGTTTTGGGATG-3’; R: 
5’-ATCCATCTAAAATATCCAACACTCC-3’). After bisulfite modification, a 50µL PCR 
was carried out in 5µL 10×PCR buffer, 4µL dNTP mixture, 1µL of each primer, 3µL 
bisulfite-modified DNA, 35.75µL ddH2O, and 0.25µL hot-start Taq-polymerase (Takara, 
Mountain View, CA). Thermal cycler conditions included an initial denaturation step of 95℃ 
for 10 min, followed by a three-step PCR program composed of 94℃ for 30 sec, 59℃ for 
30 sec, and 72℃ for 30 sec for 40 cycles, and a final extension of 72℃ for 10 min. PCR 
products were identified by 2% agarose gels and visualized under the Light Transilluminator 
(UVP, Upland, CA). 
2.3. GPX3 mRNA expression 
Total RNA was isolated from the whole blood and chondrocyte samples using Trizol Kit 
(Life Technologies, Carlsbad, CA). cDNAs were synthesized with the RevertAidTM First 
Strand cDNA Synthesis Kit (MBI, Fermentas, Vilnius, Lithuania). Relative quantification of 
GPX3 gene expression was performed using an iQe5 quantitative real-time PCR Detection 
Systems (Bio-Rad, Philadelphia, PA) and with β-actin as a reference gene. The primers used 
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for qRT-PCR were F: 5’-TTCACGACATCCGCTGGAA-3’ and R: 
5’-CATCTTGACGTTGCTGACCGT-3’ for GPX3 as well as F: 
5’-GAACGGTGAAGGTGACAGCAG-3’ and R: 5’-GTGGACTTGGGAGAGGACT-3’ for 
β-actin. Amplification was run in a 20 µL reaction mixture containing 1.6 µL of cDNA, 0.8 
µL of each primer, 10 µL 2×SYBR Premix Ex Taq Ⅱ (Takara, Mountain View, CA), and 6.8 
µL ddH2O. The reaction conditions were 94℃ for 2 min, 40 cycles at 94℃ for 10 sec, and 
60℃ for 15 sec, with a final extension at 72℃ for 30 sec. All reactions were performed in 
duplicate. The data were normalized to the expression level of β-actin and analyzed by iQe5 
software (version 2.0, Bio-Rad). 
2.4. Protein level 
Total proteins were extracted from whole blood and chondrocytes using Trizol Kit (Life 
Technologies, Carlsbad, CA) according to the manufacturer’s instructions. Samples were 
separated by 10% SDS-PAGE and transferred to NC membranes (Millipore Ireland BV, Cork, 
Ireland). The membranes were blocked with 5% non-fat-milk at 37℃ for 1 hour. The 
primary antibodies against Gβγ, PI3Kp110, pAkt, c-fos, total Akt and β-actin were diluted 
with a ratio of 1: 500 (all purchased from Sigma, Fremont, CA) and incubated overnight at 
4℃. After immunoreactive bands were detected with anti-rabbit IgG (1:10,000 dilution) 
(Pierce Company, WI), blots were developed using enhanced chemiluminescence (ECL) and 
visualized by gel imaging system (GDS-8000). 
2.5. Oxidative damage induced by tBHP in C28/I2 human chondrocytes 
The human C28/I2 chondrocytes (a human cell line provided by Dr. Mary Goldring from 
Cornell University) were cultured in DMEM/F-12 (Hyclone, Logan, UT) containing 12% 
(v/v) fetal bovine serum (SiJiQing Bio-Technique Co. Ltd., Zhejiang, China) and 1% (v/v) 
penicillin-streptomycin solution in a humidified incubator with 5% CO2 at 37℃. When the 
cells grew and reached 90% confluence in dishes, they were seeded on 96-well culture plates. 
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The experiment was conducted in 6 groups: control group (C), purely Se group (S, 0.10 
μg/mL), tert-butyl hydroperoxide (tBHP) injury group (O, tBHP 150 μmol/L), low Se group 
(OS1, 0.05 μg/mL Na2SeO3 + 150 μmol/L tBHP), medium Se group (OS2, 0.10 μg/mL 
Na2SeO3 + 150 μmol/L tBHP) and high Se group (OS3, 0.15 μg/mL Na2SeO3 + 150 μmol/L 
tBHP). OS1, OS2 and OS3 were treated with different concentrations of Na2SeO3 (0.05, 0.10 
and 0.15 μg/mL) for 24 hours, and then treated with 150 μmol/L tBHP for 24 hours. 
2.6. Chondrocyte apoptosis 
Chondrocytes were stained with 2% Hoechst 33342 in DMEM/F-12 containing 12% fetal 
bovine serum and then incubated at 37℃ for 30 min. Apoptotic chondrocytes with clear 
condensation and small bright nuclei were evaluated using a fluorescence microscope. The 
apoptotic rate of chondrocytes were measured using flow cytometry. Chondrocytes were 
collected and stained with Annexin V-FITC/PI according to the manufacturer’s instructions 
(ROCHE, Basle, Switzerland). Cell fluorescence was detected by flow cytometry (BD, CA), 
and counts and percentages of live (annexin V-/PI-), early apoptotic (annexin V+/PI-), or late 
apoptotic/necrotic (annexin V+/PI+) cells were obtained. The apoptotic rates were analyzed 
using Cell Quest software version 1.0 (BD, Franklin Lakes, NJ). 
2.7. Statistical analysis 
The Kolmogorov-Smirnov test was used to evaluate the normality of the distribution. 
Continuous variables were denoted by mean ± standard deviation (SD), and differences in 
measured assays between two groups were assessed by two-tailed Student’s t-test, as well as 
the differences among three or more groups were examined by one-way ANOVA. 
Categorical variables were presented as frequency counts, and differences in these variables 
were compared by Chi-square test. Odds ratio (OR) and 95% confidence interval (CI) were 
calculated to evaluate risk of KBD in relation to GPX3 methylation. A p-value of <0.05 
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(two-sided) was considered statistically significant. All statistical analyses were performed 
with the SPSS 23.0 software (SPSS Inc., Chicago, IL). 
3. Results 
3.1. Demographic characteristics of study population 
The baseline characteristics of the study population are shown as follows. Mean age (SD) 
was 51.9 (3.4) years for 288 KBD patients (151 men and 137 women) and 52.3 (3.8) years 
for 362 controls (168 men and 194 women). There were no significant differences in age (p = 
0.16) and sex (p = 0.13) composition between the patients and controls. 
Furthermore, 50 cases and 50 controls were randomly selected from the above population 
for detection of GPX3 methylation and gene expression. The demographic characteristics of 
the samples were shown in Table 1. No statistically significant differences were observed 
between both groups in age (P=0.202) and sex (P=0.841). 
3.2. GPX3 methylation in whole blood 
The GPX3 methylation status of peripheral blood mononuclear cells (PBMCs) procured 
from 50 KBD patients and 50 healthy controls were examined using MSP. These patients and 
controls were randomly selected from all patients and controls enrolled to the present study. 
Complete methylation of GPX3 was identified in 16% of KBD patients, but only in 2% of 
controls (p = 0.036). Results showed that the GPX3 hypermethylation were associated with 
an increased risk of KBD [OR (95% CI): 9.33, 95% (1.12~77.7)]. 
3.3. mRNA expression of GPX3 in KBD patients 
GPX3 mRNA level in whole blood was determined by qRT-PCR, and β-actin cDNA was 
the reference in the experiments. Results showed that GPX3 expression levels were 
significantly reduced in KBD patients compared with those of health individuals (p = 0.001) 
(Figure 1A). 
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3.4. Protein level of PI3K/Akt/c-fos signaling pathway in KBD patients 
The levels of Gβγ (11.2 fold), PI3Kp110 (1.89-fold), pAkt (3.27-fold), and c-fos 
(16.5-fold) were significantly increased in KBD group compared with those of control group 
(all p < 0.001) (Figure 2), suggesting that PI3K/Akt/c-fos signaling pathway was 
overexpressed in KBD patients. 
3.5. Alterations in oxidatively injured chondrocytes 
tBHP was used to induce the oxidatively damaged chondrocyte model. The effects of 
oxidative stress on cell apoptosis, methylation and mRNA level of GPX3, and protein levels 
of PI3K/Akt/c-fos were evaluated in human C28/I2 chondrocytes. Results with hoechst33342 
staining showed that the number of chondrocyte apoptosis in tBHP injury group (65.96 ± 
3.98) was significantly increased compared with that of the control group (1.30 ± 0.32). 
However, the number of chondrocyte apoptosis was decreased in all three selenium 
supplement groups (OS1: 14.54 ± 2.02, OS2: 4.15 ± 0.19, OS3: 14.74 ± 2.56) compared with 
tBHP injury group (p < 0.05) (Figure 3). The late apoptotic rate of chondrocytes in C, S, O, 
OS1, OS2, and OS3 groups were 0.09%, 7.05%, 41.01%, 39.47%, 36.75% and 29.36%, 
respectively (Figure 4). The late apoptotic rate of chondrocyte in O group was increased 
compared with C group, but it was reduced in OS1, OS2, OS3 groups, suggesting that Se 
supplement at concentrations from 0.05 μg/mL to 0.15 μg/mL could decrease apoptotic rate 
in human C28/I2 chondrocytes and exert a dose-dependent trends. 
Complete methylation and unmethylation of GPX3 was observed in the oxidative injury 
group and control group, respectively, indicating that oxidative damage resulted in 
methylation of this gene (Table 2). GPX3 expression was lower in the tBHP injury group than 
in the control group (p < 0.001) (Figure 1B). Protein levels of Gβγ, PI3Kp110, pAkt and 
c-fos were detected in chondrocytes. As shown in Figure 5, the protein levels of Gβγ, 
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PI3Kp110, pAkt, and c-fos were increased in the tBHP group compared with those of the 
control group (all p < 0.0001). 
3.6. GPX3 expression under different methylation status in chondrocytes 
The results revealed that there was a significant difference on mRNA levels of GPX3 
among the three groups (p < 0.0001). The mRNA level of GPX3 in unmethylation group was 
higher than that in partial methylation group and in complete methylation group (all p < 0.01), 
while mRNA level of GPX3 was higher in the partial methylation group than in complete 
methylation group (p < 0.01). These results indicate that reduced GPX3 gene expression was 
mediated through by its increased methylation (Figure 1C). 
3.7. Protein levels of PI3K/Akt/c-fos signaling in relation to methylation status in 
chondrocytes 
Compared with unmethylation group, protein levels of Gβγ, PI3Kp110, pAkt, and c-fos 
were increased in partial methylation group (all p < 0.01) and complete methylation group 
(all p < 0.01). The protein levels of Gβγ, PI3Kp110, and c-fos in partial methylation group 
were significantly higher than those in complete methylation group (all p < 0.01) (Figure 6), 
suggesting that the down-regulation of PI3K/Akt/c-fos protein level was correlated with a 
decreased GPX3 methylation. 
3.8. Effects of Selenium on expression and methylation of GPX3 and PI3K/Akt/c-fos signaling 
in chondrocytes 
It was found that GPX3 was completely methylated in the tBHP injury group, partially 
methylated in low Se and medium Se groups, and unmethylated in high Se group (Table 2), 
suggesting that selenium supplementation reduced GPX3 methylation. The GPX3 mRNA 
expression was significantly up-regulated in Se supplementation group than in the tBHP 
injury group (all p < 0.01) (Figure 1B). Our results revealed that down-regulated GPX3 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 12 
expression was related to GPX3 hypermethylation in chondrocytes and Se treatment could 
up-regulate the mRNA expression levels of GPX3. 
Compared with the O group, a significant reduction in protein levels were found for 
PI3Kp110 in OS2 and OS3 groups, Gβγ in OS1 and OS2, pAkt in OS3 group, and c-fos in 
three Se supplementation groups (all p < 0.01) (Figure 5). These results suggest that there are 
a significantly up-regulated protein levels of PI3K/Akt/c-fos when chondrocytes are damaged 
by oxidative stress and that selenium supplementation can down-regulate protein levels of 
PI3K/Akt/c-fos signaling. 
4. Discussion 
The characteristics of pathological changes in KBD are the necrosis and excessive 
apoptosis in articular and epiphyseal plate cartilages. Oxidative stress has been identified to 
contribute to the pathogenesis of KBD (3). The serum levels of thiobarbituric acid were 
higher and GPX levels were lower in KBD patients than in controls, suggesting that selenium 
deficiency may alter oxidative stress in cartilage tissues (2). Recent studies have revealed that 
oxidative stress induced epigenetic dysregulation (10, 21), and accumulation of excess 
cellular reactive oxygen species resulted in increased DNA mutations and subsequent 
carcinogenesis (22). An increasing body of evidence has demonstrated that GPX3 promoter 
hypermethylation are present in several cancers (21-26). In addition, an in vitro reduction in 
GPX3 expression was associated with an elevated generation of reactive oxygen species and 
an increased formation of DNA damage in complex diseases or abnormal health conditions 
such as cancer and metabolic syndrome (10, 23). To date, however, little is known about the 
patterns of GPX3 promoter methylation in KBD. 
In the present study, we investigated the status of GPX3 promoter methylation between 
KBD patients and healthy controls. It was found that the frequency of GPX3 DNA 
methylation was significantly higher in KBD patients than in controls. In addition, GPX3 
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hypermethylation was associated with a more than 9-fold increased risk of KBD. Our study 
offers novel evidence supporting that GPX3 promoter hypermethylation might be partially 
involved in the pathogenesis and etiology of KBD. DNA methylation and tissue-specific gene 
expression are the most common epigenetic alterations. DNA methylation has been used as 
biomarkers for early diagnosis, progression, and prognosis of various cancers (22-24). Our 
results showed that the expression of GPX3 was significantly down-regulated in KBD 
patients compared with healthy controls, indicating that DNA methylation might suppresses 
the expression of GPX3. Sabrina et al. (10) reported that GPX activity depended on the 
transcription levels of its related genes, which were themselves subject to regulation by 
methylation of their promoter regions. Therefore, it is possible that GPX3 expression was 
silenced in KBD patients related to GPX3 hypermethylation, resulting in reduced GPX3 
activity and subsequent compromised antioxidative and antiapoptotic functions. 
Although GPX3 promoter hypermethylation induced by oxidative stress has been 
observed to down-regulate its expression, other mechanisms modulating GPX3 expression 
are not well understood. DNA methylation is involved not only in transcriptional regulation 
and DNA damage repair, but also in intracellular signal transduction (10). PI3K/Akt/c-fos is 
the predominant signaling pathway of chondrocyte proliferation, growth, and apoptosis (27, 
28). Similarly, GPX3 methylation is related to cell apoptosis (29). Therefore, we attempted to 
explore the relationship between GPX3 methylation and PI3K/Akt/c-fos signaling pathway. 
Of note, we found that the protein levels of Gβγ, PI3Kp110, pAkt and c-fos in KBD patients 
were significantly elevated in KBD patients, indicating that PI3K/Akt/c-fos signaling is 
substantially enhanced in KBD patients. 
Several studies have demonstrated that the excessive apoptosis of chondrocytes and 
oxidative stress plays a critical role in the pathophysiology of KBD (30, 31); however, the 
underlying mechanisms remain unclear. The present study explored the mechanisms of GPX3 
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methylation in oxidatively damaged chondrocytes. We found that GPX3 was completely 
methylated in oxidative damage group, but was unmethylated in control group and purely Se 
group. Furthermore, downregulated GPX3 expression was observed in oxidative damage 
group. These results indicated that oxidative stress could result in epigenetic dysregulation in 
chondrocytes. We also investigated the mRNA levels of GPX3 and protein levels of 
PI3K/Akt/c-fos signaling molecules under different degrees of GPX3 DNA methylation. It 
was found that the mRNA levels of GPX3 was significantly decreased in the complete 
methylation group compared with unmethylation group. The protein levels of PI3K/Akt/c-fos 
were higher in complete methylation group than in unmethylation group. Taken together, our 
study suggests that GPX3 promoter methylation might be associated with the downregulation 
of GPX3 and that the PI3K/Akt/c-fos signaling pathways is up-regulated by hypermethylation 
of GPX3. Hypermethylation status was often accompanied by an increased apoptosis of 
chondrocytes. Of particular interest is that aforementioned findings were similar to those 
obtained from KBD patients. Our study provides additional evidence for a role of GPX3 
hypermethylation in chondrocyte apoptosis. Potential mechanisms for this observation might 
be that chondrocyte apoptosis arises as a consequence of GPX3 inactivation mediated through 
its hypermethylation and elevated levels of proteins involved in PI3K/Akt/c-fos signaling 
pathway. Similar findings were reported in several studies of multiple cancers in which GPX3 
expression was down-regulated by its promoter hypermethylation, leading to reduced GPX3 
capacity against oxidative damage (14, 20, 24, 25, 32). 
Epigenetics is a biological process that is modulated by environmental factors, especially 
nutrition (10). Selenium is a micronutrient that serves as a co-factor of GPX, a primary 
antioxidant enzyme. As mentioned above, selenium deficiency is a main risk factor of KBD, 
but its effects on cartilage damage are not fully understood. Therefore, it is important to 
elucidate biological mechanisms by which selenium deficiency is implicated in the etiology 
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and molecular pathogenesis of KBD. Inadequate selenium nutritional status has also been 
linked to a variety of human diseases, including cancer and cardiovascular disease (33, 34). 
Recent studies have demonstrated that selenium plays an important role in epigenetic 
transcriptional regulation. Selenium can modulate DNA and histones to activate 
methylation-silenced genes (13) and regulate inflammatory gene expression at the epigenetic 
level (12). As the methylation is a reversible process, removal of methylation could restore 
GPX3 gene function (22). Our study showed that selenite treatment resulted in promoter 
DNA demethylation and reexpression of GPX3 as well as downregulation of protein levels of 
PI3K/Akt/c-fos. All of these changes might promote anti-apoptosis. Our study demonstrates 
that methylation status of GPX3 could be reversed by selenium supplementation. Specifically, 
selenium could activate methylation-silenced GPX3 gene by modifying DNA methylation 
and regulating PI3K/Akt/c-fos signaling pathway in chondrocytes. 
In conclusion, our results showed that GPX3 promoter hypermethylation and 
down-regulated expression of GPX3 gene in KBD patients. Furthermore, GPX3 
hypermethylation down-regulates its expression and up-regulates the proteins in the 
PI3K/Akt/c-fos signaling pathway. Selenium significantly protected against tBHP-induced 
chondrocyte apoptosis, possibly mediated through reduced GPX3 DNA methylation, 
increased GPX3 gene expression, and decreased PI3K/Akt/c-fos signaling. The findings of 
the present study will provide a new insight into the pathogenesis, etiology, and prevention of 
KBD. 
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Figure legends 
 
Figure 1. The GPX3 expression in KBD patients and chondrocytes. (A) The expression of 
GPX3 in whole blood among KBD patients and controls. The mRNA levels of GPX3 were 
significantly down-regulated in KBD group as compared with control group (p = 0.001). (B) 
The GPX3 expression in cultured human C28/I2 chondrocyte. The expression levels of GPX3 
were lower in the O group than in the C group (p < 0.001). Compared with the O group, the 
GPX3 expressions in three Se supplement group were up-regulated significantly (p < 0.05). C: 
control group. S: purely Se group (0.05 μg/mL Na2SeO3). O: tBHP injury group (tBHP 150 
μmol/L). OS1: low Se group (0.05 μg/mL Na2SeO3 + 150 μmol/L tBHP). OS2: medium Se 
group (0.1 μg/mL Na2SeO3 + 150 μmol/L tBHP). OS3: high Se group (0.15 μg/mL Na2SeO3 
+ 150 μmol/L tBHP). (C) The GPX3 expressions in chondrocyte under different methylation 
status. The mRNA level of GPX3 in unmethylation group was higher than that in partial 
methylation group and in complete methylation group (all p < 0.01), while mRNA level of 
GPX3 was higher in the partial methylation group than in complete methylation group (p < 
0.01). UM: unmethylation CM: complete methylation. PM: partial methylation. 
* represents significance at p < 0.05. 
 
Figure 2. Protein levels of PI3K/Akt/c-fos in whole blood between the KBD patients and 
controls. (A) The protein level of Gβγ. (B) The protein level of PI3Kp110. (C) The protein 
level of pAkt. (D) The protein level of c-fos. All protein levels in KBD group were 
significantly higher than that in control group (p < 0.001). K1, K2 and K3: samples from 
KBD patients; C1, C2 and C3: samples from control subjects. *represents significance at p < 
0.05. 
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Figure 3. The apoptosis numbers were detected by Hoechst 33342 staining in human C28/I2 
chondrocyte. Compared with C and S groups, the apoptosis numbers were obviously 
increased in O group, while the apoptosis numbers were reduced by selenite treatment. C: 
Control group. S: purely Se group (0.05 μg/mL Na2SeO3). O: tBHP injury group (tBHP 150 
μmol/L). OS1: low Se group (0.05 μg/mL Na2SeO3 + 150 μmol/L tBHP). OS2: medium Se 
group (0.1 μg/mL Na2SeO3 + 150 μmol/L tBHP). OS3: high Se group (0.15 μg/mL Na2SeO3 
+ 150 μmol/L tBHP). 
 
Figure 4. The apoptosis rate were detected by Annexin V-FITC/PI double staining in 
cultured human C28/I2 chondrocyte. (A) Annexin V-FITC/PI staning in chondrocytes. (B) 
The late apoptosis rate in chondrocytes. The late apoptotis rate of chondrocyte in O group 
was increased compared with C group, but it was reduced in OS1, OS2 and OS3 groups. 
Numbers in each quadrant indicated the percentage of chondrocytes labeled with annexin 
V-FITC (top left), PI (bottom right), annexin V-FITC and PI (top right), and untaged (bottom 
left). C: Control group. S: purely Se group (0.05 μg/mL Na2SeO3). O: tBHP injury group 
(tBHP 150 μmol/L). OS1: low Se group (0.05 μg/mL Na2SeO3 + 150 μmol/L tBHP). OS2: 
medium Se group (0.1 μg/mL Na2SeO3 + 150 μmol/L tBHP). OS3: high Se group (0.15 
μg/mL Na2SeO3 + 150 μmol/L tBHP). 
 
Figure 5. Protein levels of PI3K/Akt/c-fos signaling in human C28/I2 chondrocytes. (A) The 
level of Gβγ. (B) The protein level of PI3Kp110. (C) The protein level of pAkt. (D) The 
protein levels of c-fos. Compared with the C group, the protein level of Gβγ, PI3Kp110, pAkt 
and c-fos protein were increased in the O group than those of the C group (all p < 0.0001). 
Compared with the O group, a significant reduction in protein levels were found for 
PI3Kp110 in OS2 and OS3 groups, c-fos in three Se supplementation groups, Gβγ in OS1 
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and OS2 (all p < 0.01), and pAkt OS3 groups (p < 0.01). C: control group. S: purely Se group 
(0.05 μg/mL Na2SeO3). O: tBHP injury group (tBHP 150 μmol/L). OS1: low Se group (0.05 
μg/mL Na2SeO3 + 150 μmol/L tBHP). OS2: medium Se group (0.1 μg/mL Na2SeO3 + 150 
μmol/L tBHP). OS3: high Se group (0.15 μg/mL Na2SeO3 + 150 μmol/L tBHP). *represents 
significance at p < 0.05. 
 
Figure 6. The protein levels of PI3K/Akt/c-fos signaling under different methylation status of 
GPX3 in chondrocytes. (A) The protein level of Gβγ with GPX3 methylation status. (B) The 
protein level of PI3Kp110 with GPX3 methylation status. (C) The protein level of pAkt with 
GPX3 methylation status. (D) The protein level of c-fos with GPX3 methylation status. 
Compared with unmethylation group, protein levels of Gβγ, PI3Kp110, pAkt, and c-fos were 
increased in partial methylation group (all p < 0.01) and complete methylation group (all p < 
0.01). The protein levels of Gβγ, PI3Kp110, and c-fos in partial methylation group were 
significantly higher than those in complete methylation group (all p < 0.01). UM: 
unmethylation. CM: complete methylation. PM: partial methylation. 
* represents significance at p < 0.05. 
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Table 1 Demographic characteristics of the study population 
a
 The difference of age between KBD and controls was performed using t-test and no 
statistical significance. 
b
 The frequency of sex between KBD and controls was performed using x
2
-test and no 
statistical significance. 
 
Characteristics Cases (n=50) Control (n=50) Values P 
Sex, male/female 26/24 27/23 0.04 0.841 
Age, mean ± SD 51.90 ± 3.39 52.85 ± 3.98 1.285 0.202 
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Table 2. GPX3 gene methylation in chondrocytes 
Groups 
GPX3 methylation status 
p-value 
Complete 
Methylation 
n (%) 
Partial methylation 
n (%) 
Unmethylation 
n (%) 
C 0 0 24(100.00)  
S 0 0 24(100.00)  
O 23(95.83) 1(4.17) 0 <0.001
a
 
OS1 3(13.04) 20(86.96) 0 <0.001
b
 
OS2 2(8.70) 21(91.30) 0 <0.001
b
 
OS3 0 1(4.35) 22(95.65) <0.001
b
 
C: control group; S: purely selenium group (0.05 μg/mL Na2SeO3); O: tBHP injury group 
(tBHP 150 μmol/L); OS1: low selenium group (0.05 μg/mL Na2SeO3 + 150 μmol/L tBHP); 
OS2: medium selenium group (0.1 μg/mL Na2SeO3 + 150 μmol/L tBHP); OS3: high 
selenium group (0.15 μg/mL Na2SeO3 + 150 μmol/L tBHP). 
a p-value for comparing O group with C groups, b p-value for comparing O group with OS1, 
OS2, OS3. 
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Hightlights: 
1. GPX3 DNA hypermethylation and low expression of gene existed in KBD patients. 
2. Up-regulation of PI3K/Akt/c-fos in KBD patients and oxidative damage chondrocytes. 
3. Hypermethylation and low gene expression of GPX3 found in apoptotic chondrocyte. 
4. GPX3 hypermethylation related to changes in gene expression and PI3K/Akt/c-fos. 
5. Methylation, gene expression of GPX3 and PI3K/Akt/c-fos improved by Se supplement. 
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